Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
ACS Catalysis
Research Article
and methanol, also relatively high boiling compounds like
methyl pyruvate (bp 135 °C) and methyl acetoacetate (bp 169
°C) could be used as substrates.11,12 The delivery of nonvolatile
substrates containing functional groups in the gas phase,
however, is not a suitable option in most cases. In particular,
when the targeted reaction is an asymmetric transformation, the
high temperatures required to generate a gas phase can be
beyond the thermal stability of the substrates or products, or
lead to reduced chemo- or enantioselectivity. Highly
enantioselective continuous flow asymmetric catalysis with
SILP catalysts involving medium volatile substrates have been
achieved using supercritical CO2 (scCO2) as the mobile phase,
as this medium effectively combines gas-phase transport
properties with liquid-like solvation properties.13−18 Sufficient
solubility of substrates and products in the scCO2 phase is an
indispensable requirement for the realization of such processes.
Functionalized substrates of medium polarity and low volatility,
which are common in the fine-chemical and pharma industry,
do often not possess useful solubilities, however, hampering a
broad applicability of this methodology.
In this work, we present a significant extension of the original
scope of SILP catalysis to substrates with no appreciable
solubility in scCO2. This was achieved using a strategy widely
applied in supercritical fluid chromatography (SFC), i.e., mixing
scCO2 with a cosolvent, a so-called entrainer or modifier.23 The
use of modified scCO2 (modCO2) results in a mobile phase
with higher solvent strength for the solutes, yet maintaining the
compatibility with SILP catalysts as demonstrated by stable
catalyst performance over 90 h on stream in the continuous
flow Rh-catalyzed asymmetric hydrogenation of enamides with
excellent enantioselectivities of >99% ee. The mobile phase is
characterized by medium polarity and low viscosity and hence
does neither dissolve nor strip the IL film from the support,
allowing for effective IL/catalyst retention. Factors controlling
the long-term catalyst stability have been investigated, and
finally, this strategy has been successfully applied in the
asymmetric hydrogenation of a real industrial case study, an
active pharmaceutical ingredient (API) of AstraZeneca’s
portfolio.
Scheme 1. Asymmetric Hydrogenation of 1
therefore seemed an ideal case study to explore the possibility
to adapt the SILP/scCO2 system for these kinds of substrates.
In preliminary experiments, we used N-(1-phenylvinyl)-
acetamide (1a) as a model substrate possessing a structure
similar to the actual target molecule of this investigation, N-(1-
(5-fluoropyrimidin-2-yl)vinyl)acetamide (1b). Enamides 1a
and 1b are polar solids with a melting point of 89 and 123
°C, respectively. Both substrates have a negligible solubility of
<0.1 mg L−1 in scCO2 at 40 °C and pressures up to 200 bar (see
SI for determination procedure) and, hence, are not suitable for
direct use with scCO2 as a mobile phase for continuous
hydrogenation. As a possible and practical way to circumvent
this problem, we reasoned to dissolve the substrate in a suitable
solvent and then to mix this solution into the flow of scCO2 and
H2 before entering the reactor. Thus, the solvent would play
the role of a modifier for scCO2, resulting in a mobile phase
exhibiting sufficient solvent strength for substrates and products
without stripping or dissolving the ionic liquid film from the
support. In this way, reaction conditions compatible with a
highly selective transformation should be applicable. Moreover,
the delivery of the substrates as a liquid solution would be
beneficial for keeping the continuous flow setup as simple as
possible.
A sufficient solubility of the substrates 1a and 1b31 in the
modifier solvent is the initial selection criterion, as the final
polarity of the mobile phase, which will critically affect catalyst
and IL retention, can be modulated to some extent by adjusting
the ratio between substrate solution and scCO2. As possible
modifier solvents, apolar linear and cyclic alkanes were
discarded because they are not able to dissolve the polar
substrates 1 in appreciable amounts. The aromatic solvent
toluene, the medium polar dichloromethane (DCM), and
methanol as a highly polar and protic solvent were selected for
testing. As expected, the solubility of 1a increases significantly
with the polarity of the solvent (Figure 2). Next, we studied the
phase behavior of solutions of 1a in the modifier at 40 °C at
increasing CO2 pressures in order to identify a suitable process
window. For optimum mass transfer in the reaction chamber, it
is required that all components merge into a single
homogeneous phase and no substrate precipitation occurs, as
this event can cause detrimental clogging of the continuous
flow setup. In a typical experiment, the desired amount of 1a
and modifier was loaded into a 10 mL window autoclave
equipped with a magnetic stirring bar. The solution was heated
to 40 °C, and while stirring, CO2 was added stepwise via a
needle valve. After waiting for the system to equilibrate, the
phase behavior was visually monitored.
RESULTS AND DISCUSSION
■
The asymmetric hydrogenation of enamides is one of the most
explored fields of enantioselective catalysis.24 This convenient
method provides access to biologically active chiral amides and
amines and has found a number of applications at the industrial
level.25 Quite rare, however, are examples of asymmetric
hydrogenation of enamides under continuous flow condi-
tions.26,27 A prototypical example is provided by the chiral
amine (S)-5-fluoropyrimidin-2-yl-ethanamine, a key building
block for the preparation of a JAK2 kinase 119 inhibitor
previously tested at the clinical level at AstraZeneca.28 Two
different medicinal chemistry methods were devised for
producing this intermediate, the asymmetric hydrogenation
with Rh/Et-DuPhos of the enamide 1b (Scheme 1) and the
biocatalyzed transamination of the corresponding aldehyde.29,30
Whereas the latter methodology was scaled up to produce the
material on a kilogram scale, the batch-wise asymmetric
hydrogenation with Rh/Et-DuPhos was not pursued further
because of the high costs of the catalyst used at 1 mol % loading
and the tedious workup procedure for removing metal
contamination. The potential to overcome these limitations
by continuous flow operation was demonstrated recently.27 It
Pressurizing with CO2 a solution of 1a (1.0 M) in methanol
(1 mL) in a window autoclave (10 mL) resulted in a biphasic
system to up to 75 bar consisting of a gaseous phase and a
liquid phase that expanded with increasing pressure.32 At
pressures of 80 bar or higher, the system turned monophasic,
3298
DOI: 10.1021/acscatal.8b00216
ACS Catal. 2018, 8, 3297−3303